These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 14651214)

  • 21. The changes in irradiated salivary gland function of patients with head and neck tumors treated with radiotherapy.
    Someya M; Sakata K; Nagakura H; Nakata K; Oouchi A; Hareyama M
    Jpn J Clin Oncol; 2003 Jul; 33(7):336-40. PubMed ID: 12949059
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Salivary scintigraphy for assessing the protective effect of pilocarpine in head and neck irradiated tumours.
    Mateos JJ; Setoain X; Ferre J; Rovirosa A; Navalpotro B; Martin F; Ortega M; Lomeña F; Fuster D; Pavia J; Pons F
    Nucl Med Commun; 2001 Jun; 22(6):651-6. PubMed ID: 11403176
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of Amifostine to prevent radiotherapy-induced acute and late toxicity in head and neck cancer patients who had normal or mild impaired salivary gland function.
    Veerasarn V; Phromratanapongse P; Suntornpong N; Lorvidhaya V; Sukthomya V; Chitapanarux I; Tesavibul C; Swangsilpa T; Khorprasert C; Shotelersuk K; Kongthanarat Y; Panichevaluk A; Chiewvit S; Pusuwan P; Aekmahachai M; Ratchadara S; Sirilipoche S; Saengsuda Y
    J Med Assoc Thai; 2006 Dec; 89(12):2056-67. PubMed ID: 17214057
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diffusion-weighted magnetic resonance imaging for evaluation of salivary gland function in head and neck cancer patients treated with intensity-modulated radiotherapy.
    Loimu V; Seppälä T; Kapanen M; Tuomikoski L; Nurmi H; Mäkitie A; Tenhunen M; Saarilahti K
    Radiother Oncol; 2017 Feb; 122(2):178-184. PubMed ID: 27475276
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does salivary gland scintigraphy predict response to pilocarpine in patients with post-radiotherapy xerostomia?
    Cooper RA; Cowan RA; Owens SE; Jeans SP; Roberts JK; Hillel PG; Slevin NJ; Allan E; Gupta NK; Collins CD
    Eur J Nucl Med; 1999 Mar; 26(3):220-5. PubMed ID: 10079311
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Toxicity and compliance of subcutaneous amifostine in patients undergoing postoperative intensity-modulated radiation therapy for head and neck cancer.
    Thorstad WL; Chao KS; Haughey B
    Semin Oncol; 2004 Dec; 31(6 Suppl 18):8-12. PubMed ID: 15726516
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dose-response relationships within the parotid gland after radiotherapy for head and neck cancer.
    Bussels B; Maes A; Flamen P; Lambin P; Erven K; Hermans R; Nuyts S; Weltens C; Cecere S; Lesaffre E; Van den Bogaert W
    Radiother Oncol; 2004 Dec; 73(3):297-306. PubMed ID: 15588874
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preservation of oral health-related quality of life and salivary flow rates after inverse-planned intensity- modulated radiotherapy (IMRT) for head-and-neck cancer.
    Parliament MB; Scrimger RA; Anderson SG; Kurien EC; Thompson HK; Field GC; Hanson J
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):663-73. PubMed ID: 14967418
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In regard to Münter et Al. Changes in salivary gland function after radiotherapy of head and neck tumors measured by quantitative pertechnetate scintigraphy: comparison of intensity-modulated radiotherapy and conventional radiation therapy with and without amifostine. (Int j radiat oncol biol phys 2007;67:651-659).
    Messerschmidt GL; Oleka N
    Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1651-2; author reply 1652. PubMed ID: 18035221
    [No Abstract]   [Full Text] [Related]  

  • 30. A prospective study of salivary gland function in patients undergoing radiotherapy for squamous cell carcinoma of the oropharynx.
    Möller P; Perrier M; Ozsahin M; Monnier P
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 Feb; 97(2):173-89. PubMed ID: 14970776
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Submandibular gland-sparing intensity modulated radiotherapy in the treatment of head and neck cancer: sites of locoregional relapse and survival.
    Collan J; Kapanen M; Mäkitie A; Nyman H; Joensuu H; Tenhunen M; Saarilahti K
    Acta Oncol; 2012 Jul; 51(6):735-42. PubMed ID: 22150115
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Relation between uptake of 67Ga-citrate in salivary glands and irradiation doses].
    Yoshida T; Akutsu T; Komatani A; Yamaguchi K
    Kaku Igaku; 1993 Jun; 30(6):637-41. PubMed ID: 8345694
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does radiation dose to the salivary glands and oral cavity predict patient-rated xerostomia and sticky saliva in head and neck cancer patients treated with curative radiotherapy?
    Jellema AP; Doornaert P; Slotman BJ; Leemans CR; Langendijk JA
    Radiother Oncol; 2005 Nov; 77(2):164-71. PubMed ID: 16256229
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Using a reduced spot size for intensity-modulated proton therapy potentially improves salivary gland-sparing in oropharyngeal cancer.
    van de Water TA; Lomax AJ; Bijl HP; Schilstra C; Hug EB; Langendijk JA
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e313-9. PubMed ID: 21708427
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intensity modulated radiotherapy for head and neck cancer: evidence for preserved salivary gland function.
    Saarilahti K; Kouri M; Collan J; Hämäläinen T; Atula T; Joensuu H; Tenhunen M
    Radiother Oncol; 2005 Mar; 74(3):251-8. PubMed ID: 15763305
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of irradiated salivary gland function in patients with head and neck tumours treated with radiotherapy.
    Baharudin A; Khairuddin A; Nizam A; Samsuddin AR
    J Laryngol Otol; 2009 Jan; 123(1):108-13. PubMed ID: 18452635
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combination of surgical resection and HDR-brachytherapy in patients with recurrent or advanced head and neck carcinomas.
    Schiefke F; Hildebrandt G; Pohlmann S; Heinicke F; Hemprich A; Frerich B
    J Craniomaxillofac Surg; 2008 Jul; 36(5):285-92. PubMed ID: 18353667
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Quantitative assessment of irradiated salivary gland by sequential sialoscintigraphy].
    Jinnouchi S; Hoshi H; Kihara Y; Nishikawa K; Watanabe K
    Kaku Igaku; 1986 Jun; 23(6):793-9. PubMed ID: 3761731
    [No Abstract]   [Full Text] [Related]  

  • 39. Functional evaluation with intravoxel incoherent motion echo-planar MRI in irradiated salivary glands: a correlative study with salivary gland scintigraphy.
    Zhang L; Murata Y; Ishida R; Ohashi I; Yoshimura R; Shibuya H
    J Magn Reson Imaging; 2001 Sep; 14(3):223-9. PubMed ID: 11536398
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vitamin E protects salivary glands dysfunction induced by ionizing radiation in rats.
    Abedi SM; Yarmand F; Motallebnejad M; Seyedmajidi M; Moslemi D; Ashrafpour M; Bijani A; Moghadamnia A; Mardanshahi A; Hosseinimehr SJ
    Arch Oral Biol; 2015 Sep; 60(9):1403-9. PubMed ID: 26150230
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.